Salvatore Monti - Concepedia

Author

Salvatore Monti

Also Known As

Daniele Barbaro, E. Guastamacchia, M Kalisa, Monti Salvatore, Monti, S., S Monti, S. MONTI, S. Monti, SALVATORE MONTI, Salvatore MONTI

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Sapienza University of Rome Azienda Ospedaliera Sant'Andrea University of Milan University of Turin University of Perugia

About

Salvatore Monti is an author at Sapienza University of Rome specializing in medicine, urology, and human growth.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	656
2	Health Sciences	2	2	81
3	Engineering	1	1	106
4	Cell Biology	1	1	52
5	Diabetes	1	1	20

Salvatore Monti

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study Armando Bartolazzi, Fabio Orlandi, Enrico Saggiorato, The Lancet Oncology Galectin-3-expression AnalysisFollicular Thyroid NodulesMedicineSurgical PathologyHistopathology	2008	279
Importance of Gluten in The Induction of Endocrine Autoantibodies and Organ Dysfunction in Adolescent Celiac Patients Vincenzo Toscano, Fabrizio Conti, Emanuela Anastasi, The American Journal of Gastroenterology	2000	116
Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia F. Di Silverio, Salvatore Monti, Alessandro Sciarra, The Prostate	1998	111
Radiofrequency ablation for benign thyroid nodules according to different ultrasound features: an Italian multicentre prospective study Maurilio Deandrea, Francesca Garino, Alberto Mormile, European Journal of Endocrinology EngineeringRadiofrequency AblationThyroid DiseaseBenign Thyroid NodulesEndocrine Surgery	2018	106
Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Maria Rosaria Cardillo, Salvatore Monti, F. Di Silverio, IRIS Research product catalog (Sapienza University of Rome)	2003	89
Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients Giorgio Grani, Maria Chiara Zatelli, Marco Alfò, Thyroid	2020	77
Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma Alessandro Sciarra, Salvatore Monti, Vincenzo Gentile, The Prostate	2003	71
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory Livia Lamartina, Cosimo Durante, Giuseppe Lucisano, Thyroid	2017	65
Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years Maurizio Poggi, Francesco Sorrentino, Pellegrina Pugliese, Annals of Hematology Bone DiseaseBone HealthIron MetabolismLongitudinal ChangesHematology	2016	61
Androgen receptor regulation of the seladin-1/DHCR24 gene: altered expression in prostate cancer Lorella Bonaccorsi, Paola Luciani, Gabriella Nesi, Laboratory Investigation UrologyHormonal ReceptorTumor SuppressorProstatic DiseaseSeladin-1/dhcr24 Gene	2008	52

Page 1